CClinicalTrials.gg
CompletedNCT00851760Updated Aug 4, 2009

Epiretinal Macular Membrane and Cataract Extraction

An interventional study of Consecutive surgery and Combined surgery in Epiretinal Macular Membrane and Cataract Extraction, sponsored by Centre Hospitalier Universitaire Dijon. Completed at 1 site in France. Open to participants aged 50 Years to 90 Years. Per ClinicalTrials.gov, last updated 2009-08-04.

Sponsored by Centre Hospitalier Universitaire Dijon · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
174
Allocation
Non-randomized
Ages
50 Years to 90 Years
Sex
All
01

Study summary

The investigators proposed to assess the functional and anatomical outcomes of cataract and idiopathic epiretinal macular membrane extraction in combined and consecutive surgeries.

Read the detailed description

A retrospective nonrandomized clinical case series study collected 174 consecutive eyes of 174 patients undergoing macular surgery between January 2005 and December 2006. Patients suffering from epiretinal macular membranes (ERM) secondary to uveitis, trauma, or associated with a simultaneous retinal detachment (RD) were excluded. We treated 109 eyes with a combined procedure (group 1) and 65 eyes with a consecutive surgery (membrane surgery and cataract separately)(group 2).

02

Conditions studied

  • Epiretinal Macular Membrane
  • Cataract Extraction

Browse trials for

03

In context

Cataract

1,701 studies on the registry are indexed under Cataract; 230 are open to participants now.

This study's enrollment of 174 is above the median of 80 across 1,155 interventional studies indexed under Cataract.

Browse Cataract studies →

Lead sponsor

Centre Hospitalier Universitaire Dijon is the lead sponsor of 495 studies on the registry; 105 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
50 Years to 90 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • All patients had symptomatic visual loss and needed vitrectomy for ERM removal.

Exclusion criteria

Exclusion Criteria:

  • Patients suffering from ERM secondary to uveitis, trauma, or associated with a simultaneous RD were excluded.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
174 participants (actual)

Study arms

  • Experimental
    1 Combined Surgery

    Procedure: Combined surgery

  • Active comparator
    2 consecutive surgery

    Procedure: Consecutive surgery

Interventions

  • ProcedureConsecutive surgery

    Consecutive surgery for epiretinal macular membrane and cataract extraction

  • ProcedureCombined surgery

    Combined surgery for epiretinal macular membrane and cataract extraction

06

What researchers measure

Primary outcomes

  1. Combined and consecutive surgeries are effective procedures to treat idiopathic ERM. The functional and anatomical results are equivalent in both procedures.

07

Study locations

1 site
  • Ophthalmology Unit CHU Dijon
    Dijon, Burgundy 21000, France
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 4, 2009, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT00851760
Lead sponsor
Centre Hospitalier Universitaire Dijon
First posted
Feb 26, 2009
Start date
Jan 2005
Primary completion
Dec 2006
Completion
Sep 2007
Last update
Aug 4, 2009

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2009. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion